January 16, 2019, MedPage Today  

Clinicians should offer medications that may reduce the risk of breast cancer in postmenopausal women who are at high risk for breast cancer, but these medications should not be routinely offered for women who are not at increased risk, according to the U.S. Preventive Services Task Force (USPSTF). 

Read more.